[Ip-health] Senator Bernie Sanders Asks USTR to Endorse Waiver of WTO Patent Rules for Least Developed Countries

Jamie Love james.love at keionline.org
Mon Sep 28 12:24:44 PDT 2015

So Peter Pitts, as an expert on medicines, is it your opinion that the
people living in the poorest countries would not benefit from access to new
drugs, under patent, if they were available as affordable generic drugs?
And if so, how does that square with your consistent promotion of the
medical benefits of those same new drugs?

On Mon, Sep 28, 2015 at 3:19 PM, Peter Pitts <ppitts at cmpi.org> wrote:

> Weak end at Bernie’s
> Ahead of a Trans-Pacific Partnership (TPP) ministerial meeting later this
> week, a naïve attempt by the Senator from Ben & Jerry’s to generate some
> post-Papal ink …
> WASHINGTON, Sept. 28 – Sen. Bernie Sanders (I-Vt.) today asked the chief
> trade representative for the United States to ensure people in the poorest
> countries around the world have access to low-cost medicines.
> “Making sure people in poor countries have access to life-saving medicine
> is our moral responsibility,” Sen. Sanders wrote. “The European Commission
> and the Holy See both support a permanent exception for drug patents for
> these poor countries. The United States government should support this as
> well. Lives are at stake.”
> Bernie, FYI -- When you examine the WHO’s model Essential Drug List, very
> few of the 400 or so drugs deemed essential are new, or patented or were
> ever patented in the world’s poorest countries.  In category after
> category, from aspirin to Zithromax, in almost every case and in almost
> every country, these medicines have always been (or have been for many
> years) in the public domain.  That is, the medicine is fully open to legal
> and legitimate generic manufacture.
> As John Adams said, “Facts are pesky things.”
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org

James Love.  Knowledge Ecology International
KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:
+41.76.413.6584, twitter.com/jamie_love

More information about the Ip-health mailing list